Intelligent bio solutions inc. announces preliminary unaudited fiscal third quarter and nine-month revenue results

Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended march 31, 2024, with highest quarterly cartridge sales since 2022 intelligent fingerprinting acquisition year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended march 31, 2024, with highest quarterly cartridge sales since 2022 intelligent fingerprinting acquisition
INBS Ratings Summary
INBS Quant Ranking